Summary
This prediction ended on 09.09.13 with a price of €83.46. With a performance of 9.02%, the BUY prediction by DirectorDealer_Intensive for Bayer AG closed with a slight gain. DirectorDealer_Intensive has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 8.990% | 8.990% | 81.080% | -30.947% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by DirectorDealer_Intensive for this prediction
In the thread Bayer AG diskutieren
Director Dealing: Kauf
Director Dealing / Insider Kauf von Börsig, Dr. Clemens (Aufsichtsorgan)
- Handelstag: 05.03.13
- Volumen: 20324 €
- Meldender: Börsig, Dr. Clemens
Wir werten alle Insider Käufe aus. Gemeinsam mit der Universität Innsbruck wurde eine Handelsstrategie auf Basis des Intensive Tradings entwickelt. Mehr Informationen finden Sie im Profil von DirectorDealer_Intensive
.
Director Dealing / Insider Kauf von Schmidt-Kiessling, Michael (Aufsichtsorgan)
- Handelstag: 06.03.13
- Volumen: 20324 €
- Meldender: Schmidt-Kiessling, Michael
(Laufzeit überschritten)